We are live on
!
Find out more
Kiniksa Pharmaceuticals
KNSA
KNSA
176 hedge funds and large institutions have $889M invested in Kiniksa Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 60 increasing their positions, 58 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
94% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 18
15% more capital invested
Capital invested by funds: $773M → $889M (+$116M)
10% more funds holding
Funds holding: 160 → 176 (+16)
1.31% more ownership
Funds ownership: 94.01% → 95.32% (+1.3%)
6% more call options, than puts
Call options by funds: $2.7M | Put options by funds: $2.55M
3% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 58
Holders
176
Holders Change
+16
Holders Change %
+10%
% of All Funds
2.36%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
35
Increased
60
Reduced
58
Closed
18
Calls
$2.7M
Puts
$2.55M
Net Calls
+$151K
Net Calls Change
+$175K
Top Buyers
Top Sellers
| 1 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$31.3M |
| 2 |
B
Braidwell
Stamford,
Connecticut
|
-$30.7M |
| 3 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
-$22.5M |
| 4 |
Morgan Stanley
New York
|
-$8.47M |
| 5 |
JP Morgan Chase
New York
|
-$7.44M |
